{"id":58149,"date":"2023-10-03T16:01:17","date_gmt":"2023-10-03T14:01:17","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\/"},"modified":"2023-10-03T16:01:17","modified_gmt":"2023-10-03T14:01:17","slug":"new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\/","title":{"rendered":"New Physician Guidelines Recommend Contrast Enhanced Ultrasound to Diagnose Certain Liver Cancers"},"content":{"rendered":"
\n

CHICAGO–(BUSINESS WIRE)–New physician guidelines now recommend use of contrast-enhanced ultrasound (CEUS) to diagnose hepatocellular carcinoma (HCC), the most common primary liver cancer.<\/p>\n

<\/a>
<\/a><\/p>\n

\nCEUS is a relatively simple, low-cost, non-invasive diagnostic imaging modality that is safely and routinely used worldwide to enhance conventional diagnostic ultrasound imaging, according to the International Contrast Ultrasound Society (ICUS), a nonprofit medical society that offers free CME-accredited webinars on CEUS and other services for the global CEUS community.<\/p>\n

\n\u201cRecent studies demonstrate sufficiently high test performance for CEUS as a diagnostic modality,\u201d according to the new Practice Guidance on Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma published by the American Society for the Study of Liver Disease (AASLD).<\/p>\n

\nThe new guidelines recommend CEUS for diagnosing HCC when MR and CT are inconclusive, unavailable or contraindicated.<\/p>\n

\nLiver cancer is the third leading cause of cancer-related deaths, and HCC disproportionately affects American Indian, Hispanic and Black patients when compared to non-Hispanic White persons, according to AASLD.<\/p>\n

\n\u201cWe are concerned that without access to CEUS, minority patients with limited access to alternative imaging may be at even greater risk for misdiagnosis or missed diagnosis,\u201d said Dr. Yuko Kono, a professor of radiology and medicine at the University of California San Diego. Dr. Kono is a past chair of the American College of Radiology Liver Imaging & Reporting Data Systems (LI-RADS) CEUS Working Group and is a member of the board of directors of ICUS.<\/p>\n

\nCEUS uses FDA-approved \u201cmicrobubble\u201d ultrasound contrast agents (UCAs) that are administered intravenously during an ultrasound scan. UCAs do not contain dye, create no known risk of kidney damage or deposit of contrast media in the brain, and do not expose patients or hospital staff to ionizing radiation.<\/p>\n

\nCEUS may be used to identify and characterize tumors, monitor chronic gastro-intestinal diseases, diagnose heart and vascular disease, evaluate other serious medical conditions and monitor therapy.<\/p>\n

\n\u201cCEUS scans are very reliable for HCC diagnosis, with accuracy equivalent to MR and CT,\u201d according to Dr. Andrej Lyshchik, a professor of radiology at Thomas Jefferson University in Philadelphia. Dr. Lyshchik currently chairs the ACR LI-RADS CEUS Working Group and is a member of both the LI-RADS Steering Committee and the board of directors of ICUS.<\/p>\n

\nHe said that CEUS also is safer and less expensive than alternative forms of diagnostic imaging, and it provides diagnostic information in real time.<\/p>\n

\n\u201cIn some cases, CEUS can avoid delays associated with MR or CT, and that can help speed up the patient\u2019s access to appropriate therapy,\u201d Dr. Lyshchik added.<\/p>\n

\nAASLD guidelines are widely followed by physicians throughout North America, and the new CEUS recommendations \u201crepresent an important and appropriate step forward in integrating CEUS into modern imaging labs,\u201d said Kono.<\/p>\n

\nCEUS is also recommended by guidelines promulgated by professional societies around the world, according to Dr. Fabio Piscaglia, a professor of internal medicine at the University of Bologna and a past president of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB). Dr. Piscaglia also is first author of the EFSUMB guidelines on non-hepatic clinical applications of CEUS, a co-author of HCC guidelines of the European Association of the Study of Liver, and a board member of ICUS.<\/p>\n

\n\u201cCEUS is a very reliable, safe, low-cost diagnostic modality that improves patient outcomes and experiences, and often saves lives,\u201d Dr. Piscaglia said.<\/p>\n

\nUCAs are manufactured and sold in the US and elsewhere by Bracco, Lantheus and GE Healthcare.<\/p>\n

\nABOUT ICUS:<\/b><\/p>\n

\nThe International Contrast Ultrasound Society (ICUS) is a nonprofit medical society dedicated to advancing the safe and medically appropriate use of contrast enhanced ultrasound (CEUS) to improve patient care globally. Membership in ICUS is available free of charge and there is no fee for ICUS CME-accredited educational programs, newsletters or other resources.<\/p>\n

\nTo join ICUS and learn more about CEUS, download ICUS Connect and visit the ICUS website (www.icus-society.org<\/a>).<\/p>\n

Contacts<\/b> <\/p>\n

\nInternational Contrast Ultrasound Society
\n
<\/b>Linda Maiman Feinstein, Advisor
\n
847-624-1844 or 312-876-2563
\n
Linda.Feinstein@Dentons.com<\/a><\/p>\n

\nRobin J. Adams, Director of Communication
\n
202-408-3946
\n
Robin.Adams@Dentons.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CHICAGO–(BUSINESS WIRE)–New physician guidelines now recommend use of contrast-enhanced ultrasound (CEUS) to diagnose hepatocellular carcinoma (HCC), the most common primary liver cancer. CEUS is a relatively simple, low-cost, non-invasive diagnostic imaging modality that is safely and routinely used worldwide to enhance conventional diagnostic ultrasound imaging, according to the International Contrast Ultrasound Society (ICUS), a nonprofit … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58149","6":"format-standard","7":"category-industry"},"yoast_head":"\nNew Physician Guidelines Recommend Contrast Enhanced Ultrasound to Diagnose Certain Liver Cancers - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New Physician Guidelines Recommend Contrast Enhanced Ultrasound to Diagnose Certain Liver Cancers - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHICAGO–(BUSINESS WIRE)–New physician guidelines now recommend use of contrast-enhanced ultrasound (CEUS) to diagnose hepatocellular carcinoma (HCC), the most common primary liver cancer. CEUS is a relatively simple, low-cost, non-invasive diagnostic imaging modality that is safely and routinely used worldwide to enhance conventional diagnostic ultrasound imaging, according to the International Contrast Ultrasound Society (ICUS), a nonprofit ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-03T14:01:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20231003931056\/en\/1905546\/21\/ICUS_logo_June_2022.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"New Physician Guidelines Recommend Contrast Enhanced Ultrasound to Diagnose Certain Liver Cancers\",\"datePublished\":\"2023-10-03T14:01:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\\\/\"},\"wordCount\":683,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231003931056\\\/en\\\/1905546\\\/21\\\/ICUS_logo_June_2022.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\\\/\",\"name\":\"New Physician Guidelines Recommend Contrast Enhanced Ultrasound to Diagnose Certain Liver Cancers - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231003931056\\\/en\\\/1905546\\\/21\\\/ICUS_logo_June_2022.jpg\",\"datePublished\":\"2023-10-03T14:01:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231003931056\\\/en\\\/1905546\\\/21\\\/ICUS_logo_June_2022.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231003931056\\\/en\\\/1905546\\\/21\\\/ICUS_logo_June_2022.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New Physician Guidelines Recommend Contrast Enhanced Ultrasound to Diagnose Certain Liver Cancers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New Physician Guidelines Recommend Contrast Enhanced Ultrasound to Diagnose Certain Liver Cancers - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\/","og_locale":"en_US","og_type":"article","og_title":"New Physician Guidelines Recommend Contrast Enhanced Ultrasound to Diagnose Certain Liver Cancers - Pharma Trend","og_description":"CHICAGO–(BUSINESS WIRE)–New physician guidelines now recommend use of contrast-enhanced ultrasound (CEUS) to diagnose hepatocellular carcinoma (HCC), the most common primary liver cancer. CEUS is a relatively simple, low-cost, non-invasive diagnostic imaging modality that is safely and routinely used worldwide to enhance conventional diagnostic ultrasound imaging, according to the International Contrast Ultrasound Society (ICUS), a nonprofit ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\/","og_site_name":"Pharma Trend","article_published_time":"2023-10-03T14:01:17+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20231003931056\/en\/1905546\/21\/ICUS_logo_June_2022.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"New Physician Guidelines Recommend Contrast Enhanced Ultrasound to Diagnose Certain Liver Cancers","datePublished":"2023-10-03T14:01:17+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\/"},"wordCount":683,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231003931056\/en\/1905546\/21\/ICUS_logo_June_2022.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\/","url":"https:\/\/pharma-trend.com\/en\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\/","name":"New Physician Guidelines Recommend Contrast Enhanced Ultrasound to Diagnose Certain Liver Cancers - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231003931056\/en\/1905546\/21\/ICUS_logo_June_2022.jpg","datePublished":"2023-10-03T14:01:17+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20231003931056\/en\/1905546\/21\/ICUS_logo_June_2022.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20231003931056\/en\/1905546\/21\/ICUS_logo_June_2022.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/new-physician-guidelines-recommend-contrast-enhanced-ultrasound-to-diagnose-certain-liver-cancers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"New Physician Guidelines Recommend Contrast Enhanced Ultrasound to Diagnose Certain Liver Cancers"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58149","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58149"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58149\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58149"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58149"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58149"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}